Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma

Pediatr Blood Cancer. 2023 Oct;70(10):e30513. doi: 10.1002/pbc.30513. Epub 2023 Jul 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzamides / pharmacology
  • Child
  • Glioma* / drug therapy
  • Glioma* / genetics
  • Humans
  • Indazoles
  • Rho Guanine Nucleotide Exchange Factors
  • Spinal Cord

Substances

  • entrectinib
  • Benzamides
  • Indazoles
  • ARHGEF11 protein, human
  • Rho Guanine Nucleotide Exchange Factors